CELESTONE SOLUSPAN Drug Patent Profile
✉ Email this page to a colleague
When do Celestone Soluspan patents expire, and what generic alternatives are available?
Celestone Soluspan is a drug marketed by Organon and is included in one NDA.
The generic ingredient in CELESTONE SOLUSPAN is betamethasone acetate; betamethasone sodium phosphate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the betamethasone acetate; betamethasone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Celestone Soluspan
A generic version of CELESTONE SOLUSPAN was approved as betamethasone acetate; betamethasone sodium phosphate by AM REGENT on July 31st, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CELESTONE SOLUSPAN?
- What are the global sales for CELESTONE SOLUSPAN?
- What is Average Wholesale Price for CELESTONE SOLUSPAN?
Summary for CELESTONE SOLUSPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Clinical Trials: | 6 |
| Patent Applications: | 88 |
| Drug Prices: | Drug price information for CELESTONE SOLUSPAN |
| What excipients (inactive ingredients) are in CELESTONE SOLUSPAN? | CELESTONE SOLUSPAN excipients list |
| DailyMed Link: | CELESTONE SOLUSPAN at DailyMed |
Recent Clinical Trials for CELESTONE SOLUSPAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| ROC Foundation | Phase 4 |
| Loma Linda University | Early Phase 1 |
| University of Kentucky | Early Phase 1 |
Pharmacology for CELESTONE SOLUSPAN
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CELESTONE SOLUSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon | CELESTONE SOLUSPAN | betamethasone acetate; betamethasone sodium phosphate | INJECTABLE;INJECTION | 014602-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CELESTONE SOLUSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon | CELESTONE SOLUSPAN | betamethasone acetate; betamethasone sodium phosphate | INJECTABLE;INJECTION | 014602-001 | Approved Prior to Jan 1, 1982 | 3,485,854 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
